Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Peytavin

Showing results (1-10 of 306) with videos related to

Pageof 31
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|March 23, 2011
Nevirapine once daily: pharmacology, metabolic profile and efficacy data of the new extended-release formulationJean-Jacques Parienti, Gilles Peytavin
Hepatology (Baltimore, Md.)|January 20, 2016
ReplyAnders Boyd, Gilles Peytavin, Karine Lacombe
Therapie|May 26, 2009
[CCR5 antagonists: a new class of antiretrovirals]Gilles Peytavin, Vincent Calvez, Christine Katlama
The Journal of Antimicrobial Chemotherapy|September 1, 2025
Placental transfer of medications to treat COVID-19, molnupiravir, favipiravir and nirmatrelvir/ritonavir, in the ex vivo human cotyledon modelSolene Labaye, Fatima Djellali, Gilles Peytavin, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2015
Erratum for Mandelbrot et al., placental transfer of rilpivirine in an ex vivo human cotyledon perfusion modelLaurent Mandelbrot, Dominique Duro, Emilie Belissa, et al.
AIDS (London, England)|March 4, 2011
Severe insomnia related to high concentrations of raltegravirCéline Eiden, Hélène Peyriere, Gilles Peytavin, et al.
BMJ Case Reports|August 11, 2012
The hairy-print for levamisole-induced vasculitisHélène Lazareth, Gilles Peytavin, Laura Polivka, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2015
Placental transfer of rilpivirine in an ex vivo human cotyledon perfusion modelLaurent Mandelbrot, Dominique Duro, Emilie Belissa, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2014
Placental transfer of darunavir in an ex vivo human cotyledon perfusion modelLaurent Mandelbrot, Dominique Duro, Emilie Belissa, et al.
AIDS Reviews|January 24, 2006
Predictors of virologic response to ritonavir-boosted protease inhibitorsAnne-Genevieve Marcelin, Philippe Flandre, Gilles Peytavin, et al.
Pageof 31

Showing results (1-10 of 306) with videos related to

Sort By:
Pageof 31
Expert Opinion on Drug Metabolism & Toxicology|March 23, 2011
Nevirapine once daily: pharmacology, metabolic profile and efficacy data of the new extended-release formulationJean-Jacques Parienti, Gilles Peytavin
Hepatology (Baltimore, Md.)|January 20, 2016
ReplyAnders Boyd, Gilles Peytavin, Karine Lacombe
Therapie|May 26, 2009
[CCR5 antagonists: a new class of antiretrovirals]Gilles Peytavin, Vincent Calvez, Christine Katlama
The Journal of Antimicrobial Chemotherapy|September 1, 2025
Placental transfer of medications to treat COVID-19, molnupiravir, favipiravir and nirmatrelvir/ritonavir, in the ex vivo human cotyledon modelSolene Labaye, Fatima Djellali, Gilles Peytavin, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2015
Erratum for Mandelbrot et al., placental transfer of rilpivirine in an ex vivo human cotyledon perfusion modelLaurent Mandelbrot, Dominique Duro, Emilie Belissa, et al.
AIDS (London, England)|March 4, 2011
Severe insomnia related to high concentrations of raltegravirCéline Eiden, Hélène Peyriere, Gilles Peytavin, et al.
BMJ Case Reports|August 11, 2012
The hairy-print for levamisole-induced vasculitisHélène Lazareth, Gilles Peytavin, Laura Polivka, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2015
Placental transfer of rilpivirine in an ex vivo human cotyledon perfusion modelLaurent Mandelbrot, Dominique Duro, Emilie Belissa, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2014
Placental transfer of darunavir in an ex vivo human cotyledon perfusion modelLaurent Mandelbrot, Dominique Duro, Emilie Belissa, et al.
AIDS Reviews|January 24, 2006
Predictors of virologic response to ritonavir-boosted protease inhibitorsAnne-Genevieve Marcelin, Philippe Flandre, Gilles Peytavin, et al.
Pageof 31